Is There Any Hope for Vaxart Stock?
A few days ago, Vaxart (NASDAQ: VXRT) was arguably the best-performing coronavirus vaccine stock of all time. If you had invested $5,000 in the stock last year, that principal would have grown into a stunning $205,000 by Feb. 2.
But not even 24 hours later, Vaxart stock took a devastating 60% plunge the day it announced interim phase 1 data on its oral-tablet coronavirus vaccine candidate. Just what is behind the wild roller coaster ride?
Image source: Getty Images.
Source Fool.com
